TrePsy
Financiado
Towards new treatments of psychiatric disorders - a systems-oriented approach
The TrePsy project aims to integrate the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS) with leading European brain research centres in development of novel treatments of psychiatric disorders, strengthen...
The TrePsy project aims to integrate the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS) with leading European brain research centres in development of novel treatments of psychiatric disorders, strengthen research excellence at the IP PAS, and empower it to become leader in other Horizon Europe projects. To this end we will create a unique advanced research curriculum for students and early-career scientists, who will lead future neuropharmacological research, and form a cluster of institutions of excellence in the fields of Neuropsychopharmacology. The project will provide students, and PhD programme participants at the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS), as well as partner Institutes, with lectures and training in emerging topics and research methodologies. These activities will be organised through four advanced schools, each including lectures and hands-o training in advanced research methods, and additionally a University Specialist course that will be developed by the consortium. The training activities will be complemented with participation in regional science outreach events, with presentations focused on brain research, the importance of Neuropsychopharmacology-driven research. Furthermore, as an exploratory research project, we selected the study of neuronal and molecular mechanisms involved in the actions of cannabidiol. Each of the partners will contribute their unique research competence including transgenic mice and rats, a ‘multiome’ approach to gene regulation analysis with RNA-Seq and ATAC-Seq, advanced methods of imaging and controlling neuronal activity in behaving animals, and multimodal neuroimaging methodology. The planned research activities emphasize mutual benefits for all consortium partners, nevertheless, interactions with the three leading European research centres will have the greatest impact on research excellence at the IP PAS.
ver más
Duración del proyecto: 39 meses
Fecha Inicio: 2022-07-01
Fecha Fin: 2025-10-31
Fecha Fin: 2025-10-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-07-01
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-WIDERA-2021-ACCESS-03-01:
Twinning
Cerrada
hace 54 años
Presupuesto
El presupuesto total del proyecto asciende a
1M€
Líder del proyecto
INSTYTUT FARMAKOLOGII IM. JERZEGO MAJA POLSKI...
No se ha especificado una descripción o un objeto social para esta compañía.
288.75K€ |
Participante
280.50K€ |
Participante